Blood test could help rectal cancer patients avoid major surgery
NCT ID NCT05081024
Summary
This study is testing whether a simple blood test can help doctors decide if rectal cancer patients need major surgery after initial treatment. Researchers will track cancer DNA in the blood of 50 patients with stage 2-3 rectal cancer before, during, and after standard treatment. The goal is to see if the blood test results can predict which patients might safely avoid surgery and instead be monitored closely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutch
RECRUITINGSeattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
OHSU Knight Cancer Institute
RECRUITINGPortland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.